Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Phase II Study of CyberKnife® for Hepatic Metastases From Colorectal Cancer

NCT01318447 is registered in ClinicalTrials.gov with Accuray Incorporated as lead sponsor.

NCT NCT01318447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Phase II Study of CyberKnife® for Hepatic Metastases From Colorectal Cancer
Lead sponsor
Accuray Incorporated
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2011
Completion date
March 31, 2013
Enrollment
15 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal liver metastases